Physician profile
Antonio J Eppolito
NPI 1306823067
$827.34
in general payments reported to CMS, 2019-2025
8 companies · $587 in 2025
The $587 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $32.88 · 2023: $22.74 · 2024: $184 · 2025: $587.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $794.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $794.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $271.08 | 2022-2025 | |
| Gilead Sciences, INC. | $239.53 | 2023-2025 | |
| Exact Sciences Corporation | $101.39 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novo Nordisk INC | $99.80 | 2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $56.53 | 2024-2025 | Zepbound, Mounjaro |
| Glaxosmithkline, LLC. | $31.87 | 2022-2025 | Shingrix, Arexvy |
| Antares Pharma, INC. | $22.87 | 2024 | Xyosted |
| Dynavax Technologies Corporation | $4.27 | 2023 | Heplisav-B |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antonio Eppolito listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.